![](/img/cover-not-exists.png)
PCN71 A COMPARISON OF THE COST-EFFECTIVENESS OF ZOLEDRONIC ACID FOR PREVENTING SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES FROM PROSTATE CANCER IN 4 EUROPEAN COUNTRIES
M Botteman, J Carter, S KauraVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71966-0
File:
PDF, 76 KB
english, 2010